Report Content
Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates & working
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Cell line development industry 360° synopsis, 2017 – 2028
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Source trends
2.1.4 Cell line trends
2.1.5 Application trends
2.1.6 Regional trends
Chapter 3 Cell Line Development Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 – 2028
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Growing vaccine production worldwide
3.3.1.2 Increasing prevalence of cancer across the globe
3.3.1.3 Growth in biotechnology industry
3.3.1.4 Innovations in biologics due to patent expiration
3.3.1.5 Rising demand for monoclonal antibodies in developed economies
3.3.1.6 Technological innovation in cell line development
3.3.2 Industry pitfalls & challenges
3.3.2.1 Complex regulatory landscape
3.3.2.2 Issues related to stem cell research
3.4 Growth potential analysis
3.4.1 By product
3.4.2 By source
3.4.3 By cell line
3.4.4 By application
3.5 COVID-19 impact analysis
3.6 Porter’s analysis
3.7 Competitive landscape, 2021
3.8 PESTEL analysis
Chapter 4 Cell Line Development Market, By Product
4.1 Key segment trends
4.2 Reagents and media
4.2.1 Reagents and media market, by region, 2017 – 2028 (USD Million)
4.3 Equipment
4.3.1 Equipment market, by region, 2017 – 2028 (USD Million)
4.3.2 Incubators
4.3.2.1 Incubators market, by region, 2017 – 2028 (USD Million)
4.3.3 Centrifuges
4.3.3.1 Centrifuges market, by region, 2017 – 2028 (USD Million)
4.3.4 Bioreactors
4.3.4.1 Bioreactors market, by region, 2017 – 2028 (USD Million)
4.3.5 Storage equipment
4.3.5.1 Storage equipment market, by region, 2017 – 2028 (USD Million)
4.3.6 Microscopes
4.3.6.1 Microscopes market, by region, 2017 – 2028 (USD Million)
4.3.7 Electroporators
4.3.7.1 Electroporates market, by region, 2017 – 2028 (USD Million)
4.3.8 Fluorescence-activated cell sorting (FACS)
4.3.8.1 FACS market, by region, 2017 – 2028 (USD Million)
4.3.9 Others
4.3.9.1 Others market, by region, 2017 – 2028 (USD Million)
4.4 Accessories and consumables
4.4.1 Accessories and consumables market, by region, 2017 – 2028 (USD Million)
Chapter 5 Cell Line Development Market, By Source
5.1 Key segment trends
5.2 Mammalian
5.2.1 Mammalian market, by region, 2017 – 2028 (USD Million)
5.3 Non-mammalian
5.3.1 Non-mammalian market, by region, 2017 – 2028 (USD Million)
5.3.2 Insects
5.3.2.1 Insects market, by region, 2017 – 2028 (USD Million)
5.3.3 Amphibians
5.3.3.1 Amphibians market, by region, 2017 – 2028 (USD Million)
Chapter 6 Cell Line Development Market, By Cell Line
6.1 Key segment trends
6.2 Recombinant
6.2.1 Recombinant cell lines market, by region, 2017 – 2028 (USD Million)
6.3 Hybridomas
6.3.1 Hybridomas cell lines market, by region, 2017 – 2028 (USD Million)
6.4 Continuous cell lines
6.4.1 Continuous cell lines market, by region, 2017 – 2028 (USD Million)
6.5 Primary cell lines
6.5.1 Primary cell lines market, by region, 2017 – 2028 (USD Million)
Chapter 7 Cell Line Development Market, By Application
7.1 Key segment trends
7.2 Bioproduction
7.2.1 Bioproduction market, by region, 2017 – 2028 (USD Million)
7.3 Drug discovery
7.3.1 Drug discovery market, by region, 2017 – 2028 (USD Million)
7.4 Toxicity testing
7.4.1 Toxicity testing market, by region, 2017 – 2028 (USD Million)
7.5 Tissue engineering
7.5.1 Tissue engineering market, by region, 2017 – 2028 (USD Million)
7.6 Research
7.6.1 Research market, by region, 2017 – 2028 (USD Million)
Chapter 8 Cell Line Development Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 Market size, by country 2017-2028
8.2.2 Market size, by product, 2017-2028
8.2.2.1 Market size, by equipment, 2017-2028
8.2.3 Market size, by source, 2017-2028
8.2.3.1 Market size, by non-mammalian, 2017-2028
8.2.4 Market size, by cell line, 2017-2028
8.2.5 Market size, by application, 2017-2028
8.2.6 U.S.
8.2.6.1 Market size, by product, 2017-2028
8.2.6.1.1 Market size, by equipment, 2017-2028
8.2.6.2 Market size, by source, 2017-2028
8.2.6.2.1 Market size, by non-mammalian, 2017-2028
8.2.6.3 Market size, by cell line, 2017-2028
8.2.6.4 Market size, by application, 2017-2028
8.2.7 Canada
8.2.7.1 Market size, by product, 2017-2028
8.2.7.1.1 Market size, by equipment, 2017-2028
8.2.7.2 Market size, by source, 2017-2028
8.2.7.2.1 Market size, by non-mammalian, 2017-2028
8.2.7.3 Market size, by cell line, 2017-2028
8.2.7.4 Market size, by application, 2017-2028
8.3 Europe
8.3.1 Market size, by country 2017-2028
8.3.2 Market size, by product, 2017-2028
8.3.2.1 Market size, by equipment, 2017-2028
8.3.3 Market size, by source, 2017-2028
8.3.3.1 Market size, by non-mammalian, 2017-2028
8.3.4 Market size, by cell line, 2017-2028
8.3.5 Market size, by application, 2017-2028
8.3.6 Germany
8.3.6.1 Market size, by product, 2017-2028
8.3.6.1.1 Market size, by equipment, 2017-2028
8.3.6.2 Market size, by source, 2017-2028
8.3.6.2.1 Market size, by non-mammalian, 2017-2028
8.3.6.3 Market size, by cell line, 2017-2028
8.3.6.4 Market size, by application, 2017-2028
8.3.7 France
8.3.7.1 Market size, by product, 2017-2028
8.3.7.1.1 Market size, by equipment, 2017-2028
8.3.7.2 Market size, by source, 2017-2028
8.3.7.2.1 Market size, by non-mammalian, 2017-2028
8.3.7.3 Market size, by cell line, 2017-2028
8.3.7.4 Market size, by application, 2017-2028
8.3.8 UK
8.3.8.1 Market size, by product, 2017-2028
8.3.8.1.1 Market size, by equipment, 2017-2028
8.3.8.2 Market size, by source, 2017-2028
8.3.8.2.1 Market size, by non-mammalian, 2017-2028
8.3.8.3 Market size, by cell line, 2017-2028
8.3.8.4 Market size, by application, 2017-2028
8.3.9 Spain
8.3.9.1 Market size, by product, 2017-2028
8.3.9.1.1 Market size, by equipment, 2017-2028
8.3.9.2 Market size, by source, 2017-2028
8.3.9.2.1 Market size, by non-mammalian, 2017-2028
8.3.9.3 Market size, by cell line, 2017-2028
8.3.9.4 Market size, by application, 2017-2028
8.3.10 Italy
8.3.10.1 Market size, by product, 2017-2028
8.3.10.1.1 Market size, by equipment, 2017-2028
8.3.10.2 Market size, by source, 2017-2028
8.3.10.2.1 Market size, by non-mammalian, 2017-2028
8.3.10.3 Market size, by cell line, 2017-2028
8.3.10.4 Market size, by application, 2017-2028
8.3.11 Russia
8.3.11.1 Market size, by product, 2017-2028
8.3.11.1.1 Market size, by equipment, 2017-2028
8.3.11.2 Market size, by source, 2017-2028
8.3.11.2.1 Market size, by non-mammalian, 2017-2028
8.3.11.3 Market size, by cell line, 2017-2028
8.3.11.4 Market size, by application, 2017-2028
8.4 Asia Pacific
8.4.1 Market size, by country 2017-2028
8.4.2 Market size, by product, 2017-2028
8.4.2.1 Market size, by equipment, 2017-2028
8.4.3 Market size, by source, 2017-2028
8.4.3.1 Market size, by non-mammalian, 2017-2028
8.4.4 Market size, by cell line, 2017-2028
8.4.5 Market size, by application, 2017-2028
8.4.6 Japan
8.4.6.1 Market size, by product, 2017-2028
8.4.6.1.1 Market size, by equipment, 2017-2028
8.4.6.2 Market size, by source, 2017-2028
8.4.6.2.1 Market size, by non-mammalian, 2017-2028
8.4.6.3 Market size, by cell line, 2017-2028
8.4.6.4 Market size, by application, 2017-2028
8.4.7 China
8.4.7.1 Market size, by product, 2017-2028
8.4.7.1.1 Market size, by equipment, 2017-2028
8.4.7.2 Market size, by source, 2017-2028
8.4.7.2.1 Market size, by non-mammalian, 2017-2028
8.4.7.3 Market size, by cell line, 2017-2028
8.4.7.4 Market size, by application, 2017-2028
8.4.8 India
8.4.8.1 Market size, by product, 2017-2028
8.4.8.1.1 Market size, by equipment, 2017-2028
8.4.8.2 Market size, by source, 2017-2028
8.4.8.2.1 Market size, by non-mammalian, 2017-2028
8.4.8.3 Market size, by cell line, 2017-2028
8.4.8.4 Market size, by application, 2017-2028
8.4.9 South Korea
8.4.9.1 Market size, by product, 2017-2028
8.4.9.1.1 Market size, by equipment, 2017-2028
8.4.9.2 Market size, by source, 2017-2028
8.4.9.2.1 Market size, by non-mammalian, 2017-2028
8.4.9.3 Market size, by cell line, 2017-2028
8.4.9.4 Market size, by application, 2017-2028
8.4.10 Australia
8.4.10.1 Market size, by product, 2017-2028
8.4.10.1.1 Market size, by equipment, 2017-2028
8.4.10.2 Market size, by source, 2017-2028
8.4.10.2.1 Market size, by non-mammalian, 2017-2028
8.4.10.3 Market size, by cell line, 2017-2028
8.4.10.4 Market size, by application, 2017-2028
8.5 Latin America
8.5.1 Market size, by country 2017-2028
8.5.2 Market size, by product, 2017-2028
8.5.2.1 Market size, by equipment, 2017-2028
8.5.3 Market size, by source, 2017-2028
8.5.3.1 Market size, by non-mammalian, 2017-2028
8.5.4 Market size, by cell line, 2017-2028
8.5.5 Market size, by application, 2017-2028
8.5.6 Mexico
8.5.6.1 Market size, by product, 2017-2028
8.5.6.1.1 Market size, by equipment, 2017-2028
8.5.6.2 Market size, by source, 2017-2028
8.5.6.2.1 Market size, by non-mammalian, 2017-2028
8.5.6.3 Market size, by cell line, 2017-2028
8.5.6.4 Market size, by application, 2017-2028
8.5.7 Brazil
8.5.7.1 Market size, by product, 2017-2028
8.5.7.1.1 Market size, by equipment, 2017-2028
8.5.7.2 Market size, by source, 2017-2028
8.5.7.2.1 Market size, by non-mammalian, 2017-2028
8.5.7.3 Market size, by cell line, 2017-2028
8.5.7.4 Market size, by application, 2017-2028
8.6 MEA
8.6.1 Market size, by country 2017-2028
8.6.2 Market size, by product, 2017-2028
8.6.2.1 Market size, by equipment, 2017-2028
8.6.3 Market size, by source, 2017-2028
8.6.3.1 Market size, by non-mammalian, 2017-2028
8.6.4 Market size, by cell line, 2017-2028
8.6.5 Market size, by application, 2017-2028
8.6.6 South Africa
8.6.6.1 Market size, by product, 2017-2028
8.6.6.1.1 Market size, by equipment, 2017-2028
8.6.6.2 Market size, by source, 2017-2028
8.6.6.2.1 Market size, by non-mammalian, 2017-2028
8.6.6.3 Market size, by cell line, 2017-2028
8.6.6.4 Market size, by application, 2017-2028
8.6.7 Saudi Arabia
8.6.7.1 Market size, by product, 2017-2028
8.6.7.1.1 Market size, by equipment, 2017-2028
8.6.7.2 Market size, by source, 2017-2028
8.6.7.2.1 Market size, by non-mammalian, 2017-2028
8.6.7.3 Market size, by cell line, 2017-2028
8.6.7.4 Market size, by application, 2017-2028
Chapter 9 Company Profiles
9.1 Strategy dashboard, 2021
9.2 Advanced Instruments, LLC
9.2.1 Business overview
9.2.2 Financial data
9.2.3 Product landscape
9.2.4 Strategic outlook
9.2.5 SWOT analysis
9.3 AGC Biologics
9.3.1 Business overview
9.3.2 Financial data
9.3.3 Product landscape
9.3.4 SWOT analysis
9.4 Catalent
9.4.1 Business overview
9.4.2 Financial data
9.4.3 Products landscape
9.4.4 Strategic outlook
9.4.5 SWOT analysis
9.5 Corning Inc.
9.5.1 Business overview
9.5.2 Financial data
9.5.3 Product landscape
9.5.4 Strategic outlook
9.5.5 SWOT analysis
9.6 Cyagen
9.6.1 Business overview
9.6.2 Financial data
9.6.3 Product landscape
9.6.4 SWOT analysis
9.7 Cytiva (Danaher Corporation)
9.7.1 Business overview
9.7.2 Financial information
9.7.3 Product landscape
9.7.4 Strategic outlook
9.7.5 SWOT analysis
9.8 Eurofins Scientific
9.8.1 Business Overview
9.8.2 Financial data
9.8.3 Product Landscape
9.8.4 Strategic outlook
9.8.5 SWOT analysis
9.9 Fujifilm Diosynth Biotechnologies
9.9.1 Business overview
9.9.2 Financial data
9.9.3 Product Landscape
9.9.4 Strategic outlook
9.9.5 SWOT analysis
9.10 Genscript Biotech
9.10.1 Business Overview
9.10.2 Financial data
9.10.3 Product landscape
9.10.4 SWOT analysis
9.11 Horizon Discovery
9.11.1 Business Overview
9.11.2 Financial data
9.11.3 Product Landscape
9.11.4 SWOT analysis
9.12 Imgenex
9.12.1 Business overview
9.12.2 Financial data
9.12.3 Service landscape
9.12.4 SWOT analysis
9.13 Lonza Group AG
9.13.1 Business Overview
9.13.2 Financial Data
9.13.3 Product Landscape
9.13.4 Strategic Outlook
9.13.5 SWOT analysis
9.14 NAEJA RGM Pharmaceuticals
9.14.1 Business Overview
9.14.2 Financial data
9.14.3 Product Landscape
9.14.4 SWOT analysis
9.15 Novartis
9.15.1 Business overview
9.15.2 Financial data
9.15.3 Product landscape
9.15.4 Strategic outlook
9.15.5 SWOT analysis
9.16 Premas Biotech
9.16.1 Business Overview
9.16.2 Financial data
9.16.3 Product Landscape
9.16.4 SWOT analysis
9.17 ProBioGen
9.17.1 Business overview
9.17.2 Financial data
9.17.3 Product landscape
9.17.4 SWOT analysis
9.18 Promocell
9.18.1 Business overview
9.18.2 Financial data
9.18.3 Product landscape
9.18.4 Strategic outlook
9.18.5 SWOT analysis
9.19 Rentschler Biopharma SE
9.19.1 Business overview
9.19.2 Financial data
9.19.3 Service landscape
9.19.4 SWOT analysis
9.20 Samsung Biologics
9.20.1 Business overview
9.20.2 Financial data
9.20.3 Products landscape
9.20.4 Strategic outlook
9.20.5 SWOT analysis
9.21 Sartorius AG
9.21.1 Business overview
9.21.2 Financial data
9.21.3 Product landscape
9.21.4 Strategic outlook
9.21.5 SWOT Analysis
9.22 Selexis SA
9.22.1 Business overview
9.22.2 Financial data
9.22.3 Product landscape
9.22.4 Strategic outlook
9.22.5 SWOT analysis
9.23 Sigma Aldrich (Merck KGaA)
9.23.1 Business overview
9.23.2 Financial data
9.23.3 Product landscape
9.23.4 Strategic Outlook
9.23.5 SWOT analysis
9.24 Syngene International Limited
9.24.1 Business overview
9.24.2 Financial data
9.24.3 Service landscape
9.24.4 SWOT analysis
9.25 Thermo Fisher Scientific
9.25.1 Business overview
9.25.2 Financial data
9.25.3 Product landscape
9.25.4 SWOT analysis
9.26 Vista Biologics
9.26.1 Business overview
9.26.2 Financial data
9.26.3 Product Landscape
9.26.4 SWOT analysis
9.27 WuXi AppTec
9.27.1 Business overview
9.27.2 Financial data
9.27.3 Service landscape
9.27.4 Strategic outlook
9.27.5 SWOT analysis
